S&P 500 7,568.92 +0.36%
Nasdaq 25,372.01 +0.83%
S&P/TSX 35,532.28 −0.75%
Apple 331.90 −1.90%
Nvidia 206.69 +2.29%
Microsoft 520.99 +2.74%
Shopify 200.19 −8.02%
Royal Bank 285.42 −0.28%
CAD/USD 0.7157 +0.07%
CLOSED · 00:15 ET
Market ClerkRecap
Wed Nov 4 · markets closed3 signals on Nov 3175 insider buys this week · $365.2MCIRO short report next: Nov 14The week ahead
PS
INSIDER · KNSA · Kiniksa Pharmaceuticals International, plc · CHAIRMAN & CEO

Patel Sanj K

Every open-market transaction filed under this name, Oct 30 to Nov 3.

Filings
15
0 buys · 15 sells
Bought
—
open market, at cost
Sold
$37.4M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 3KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell4,584$94.25$432K—
Nov 3KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell145,708$93.53$13.6M—
Nov 3KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell68,664$92.70$6.4M—
Nov 3KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell1,214$90.77$110K—
Nov 2KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell100$93.97$9K—
Nov 2KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell26,781$93.06$2.5M—
Nov 2KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell24,188$91.83$2.2M—
Nov 2KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell38,364$91.03$3.5M—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell1,440$98.16$141K—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell2,316$97.34$225K—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell4,490$95.97$431K—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell8,888$94.72$842K—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell15,903$93.62$1.5M—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell18,685$92.77$1.7M—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHAIRMAN & CEOSell41,169$92.01$3.8M—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.